ProfoundBio

company

About

ProfoundBio is an oncology biotherapeutics company.

Details

Last Funding Type
Seed
Last Funding Money Raised
$10M
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2018
Operating Status
Active

ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$135M
ProfoundBio has raised a total of $135M in funding over 2 rounds. Their latest funding was raised on Jun 2, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 2, 2022 Series A $70M 1 Detail
Jul 12, 2021 Series A $55M 2 Lilly Asia Ventures Detail
Feb 8, 2021 Seed $10M 2 Xianfeng Qiyun Detail

Investors

Number of Lead Investors
Number of Investors
2
3
ProfoundBio is funded by 3 investors. Xianfeng Qiyun and Lilly Asia Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Xianfeng Qiyun Yes Seed
Lilly Asia Ventures Series A
Gaorong Capital Series A